CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Davidson Matt President and CEO | Conversion | +524,954 | 819,018 | ||
| 2026-11-02 | Davidson Matt President and CEO | Conversion | +101,298 | 104,725 | ||
| 2026-11-02 | Davidson Matt President and CEO | Conversion · Series A Preferred Stock | −524.95 | 1,297.18 | ||
| 2026-11-02 | Davidson Matt President and CEO | Conversion · Series A Preferred Stock | −101.3 | 0 | ||
| 2026-11-02 | Saiki Julie Chief Strategy Officer | Conversion | +626,252 | 761,636 | ||
| 2026-11-02 | Saiki Julie Chief Strategy Officer | Conversion · Series A Preferred Stock | −626.25 | 1,225.98 | ||
| 2026-10-28 | Davidson Matt President and CEO | Grant or award | +232,417 | 294,064 | ||
| 2026-10-28 | Davidson Matt President and CEO | Grant or award · Series A Preferred Stock | +1,822.13 | 1,822.13 | ||
| 2026-10-28 | Davidson Matt President and CEO | Grant or award · Series A Preferred Stock | +101.3 | 101.3 | ||
| 2026-10-28 | Davidson Matt President and CEO | Grant or award · Stock Option (Right to Buy) | +232,417 | 232,417 | ||
| 2026-10-28 | Davidson Matt President and CEO | Grant or award · Stock Option (Right to Buy) | +286,044 | 286,044 | ||
| 2026-10-28 | Davidson Matt President and CEO | Grant or award · Stock Option (Right to Buy) | +31,914 | 31,914 | ||
| 2026-10-28 | Davidson Matt President and CEO | Grant or award · Stock Option (Right to Buy) | +333,830 | 333,830 | ||
| 2026-09-17 | Young Wendy B. Director | Grant or award · Stock Option (Right to Buy) | +25,666 | 25,666 | ||
| 2026-07-16 | Coastlands Capital LP 10% owner | Purchase | +1,233 | $2.75 | $3K | 388,308 |
| 2026-07-14 | Coastlands Capital LP 10% owner | Purchase | +2,000 | $2.65 | $5K | 387,075 |
| 2026-07-10 | Coastlands Capital LP 10% owner | Purchase | +1,700 | $2.70 | $5K | 385,075 |
| 2026-07-09 | Coastlands Capital LP 10% owner | Purchase | +10,053 | $2.79 | $28K | 383,375 |
| 2026-06-29 | Coastlands Capital LP 10% owner | Purchase | +25,000 | $2.60 | $65K | 373,322 |
| 2026-06-12 | Davidson Matt Chief Development Officer | Grant or award | +232,417 | 297,491 |
Page 1 of 10 · 190 trades